Maxcyte (MXCT) EBT Margin (2020 - 2026)
Maxcyte's (MXCT) quarterly EBT Margin came in at 105.53% in Q1 2026, down 677.0% year-on-year from 18.29% in Q1 2025, and down 152.45% on a QoQ basis from 201.22% in Q4 2025.
Maxcyte (MXCT) EBT Margin (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has 7 years of EBT Margin data on file, last reported at 105.53% in Q1 2026.
- On a quarterly basis, EBT Margin fell 677.0% year-over-year to 105.53% in Q1 2026; TTM through Mar 2026 was 259.62%, a 11831.0% decrease from a year earlier, with the FY2025 full-year figure at 212.96%, down 2815.0% from the prior year.
- EBT Margin for Q1 2026 stood at 105.53%, down from 201.22% in the prior quarter.
- Over the last five years, EBT Margin for MXCT reached as high as 201.22% in Q4 2025 and fell as low as 369.04% in Q4 2022.
- Historically, EBT Margin has averaged 155.89% across 5 years, with a median of 170.59% in 2024.
- Across the five-year window, EBT Margin slumped 30466 bps in 2022 and jumped 37623 bps in 2025, its largest moves.
- Year by year, EBT Margin stood at 369.04% in 2022, then jumped by 95 bps to 19.88% in 2023, then slumped by 780 bps to 175.01% in 2024, then surged by 215 bps to 201.22% in 2025, then slumped by 152 bps to 105.53% in 2026.
- Per Business Quant data, the three most recent EBT Margin figures were 105.53% in Q1 2026, 201.22% in Q4 2025, and 181.81% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 176.24 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 129.03 Bn | 126.15 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 108.43 Bn | 99.21 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 68.74 Bn | 67.28 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn | 27.84% |
| 6 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | 22.61% |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.78 Bn | 1.98 Bn | 9.84% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 4.87% |
| 10 | Maxcyte | 109.55 Mn | 109.55 Mn | 8.08 Mn | -105.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -105.53% |
| Dec 31, 2025 | 201.22% |
| Sep 30, 2025 | -181.81% |
| Jun 30, 2025 | -145.26% |
| Mar 31, 2025 | -98.76% |
| Dec 31, 2024 | -175.01% |
| Sep 30, 2024 | -141.56% |
| Jun 30, 2024 | -188.86% |
| Mar 31, 2024 | -170.59% |
| Dec 31, 2023 | -19.88% |
| Sep 30, 2023 | -270.72% |
| Jun 30, 2023 | -116.24% |
| Mar 31, 2023 | -219.22% |
| Dec 31, 2022 | -369.04% |
| Sep 30, 2022 | -289.51% |
| Jun 30, 2022 | -104.48% |
| Mar 31, 2022 | -254.80% |
| Dec 31, 2021 | -64.39% |
| Sep 30, 2021 | -24.51% |
| Jun 30, 2021 | -64.88% |